Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/132456 |
Resumo: | Funding Information: Disclosure and potential conflicts of interest: TT has received research grants and/or consulting fees from AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, LEO Pharma, MSD, Novartis, Pfizer, Samsung-Bioepis, Sandoz and Sanofi. MG has received research grants and/or consulting fees from Abbvie, Leo, Lilly, Novartis, Pfizer, Sanofi and Takeda. MJPL has received research grants and/or consulting fees from AbbVie, Almirall, Janssen, Leo-Pharma, Lilly, Novartis, Pfizer, Sanofi and Viatris. CC has received research grants and/or consulting fees from Janssen, Sanofi-Genzyme, Procter&Gamble, Astellas, Galderma, Leo-Pharma and Mylan. MS has received research grants and/or consulting fees from Janssen, Novartis and Pfizer. PMB has received research grants and/ or consulting fees from AbbVie, Pfizer, Janssen, LEO Pharma, Novartis, Sanofi, Teva, Bayer and L’Oreal. LR, JR, RC, AM and PF have no conflicts of interest to declare. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/11/dic.2021-9-5-COI.pdf Publisher Copyright: Copyright: Copyright © 2021 Torres T, Gonçalo M, Paiva Lopes MJ, Claro C, Ramos L, Selores M, Mendes Bastos P, Rocha J, Carvalho R, Mota A, Filipe P on Behalf of the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission. |
id |
RCAP_f2439a057041183b936ebf272bcca505 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/132456 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patientsAtopic dermatitisBiologic therapyGuidelinesJAK inhibitorsRecommendationsTreatment goalsPharmacologyFunding Information: Disclosure and potential conflicts of interest: TT has received research grants and/or consulting fees from AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, LEO Pharma, MSD, Novartis, Pfizer, Samsung-Bioepis, Sandoz and Sanofi. MG has received research grants and/or consulting fees from Abbvie, Leo, Lilly, Novartis, Pfizer, Sanofi and Takeda. MJPL has received research grants and/or consulting fees from AbbVie, Almirall, Janssen, Leo-Pharma, Lilly, Novartis, Pfizer, Sanofi and Viatris. CC has received research grants and/or consulting fees from Janssen, Sanofi-Genzyme, Procter&Gamble, Astellas, Galderma, Leo-Pharma and Mylan. MS has received research grants and/or consulting fees from Janssen, Novartis and Pfizer. PMB has received research grants and/ or consulting fees from AbbVie, Pfizer, Janssen, LEO Pharma, Novartis, Sanofi, Teva, Bayer and L’Oreal. LR, JR, RC, AM and PF have no conflicts of interest to declare. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/11/dic.2021-9-5-COI.pdf Publisher Copyright: Copyright: Copyright © 2021 Torres T, Gonçalo M, Paiva Lopes MJ, Claro C, Ramos L, Selores M, Mendes Bastos P, Rocha J, Carvalho R, Mota A, Filipe P on Behalf of the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.Atopic dermatitis is a highly prevalent chronic, immune-mediated inflammatory skin disease with a significant burden on patients, families and healthcare systems. This article presents recommendations developed by the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology addressing several clinical questions that arise in the management and care of moderate-to-severe atopic dermatitis with biologic agents and Janus kinase (JAK) inhibitors based on the available evidence. The recommendations were generated after a thorough evaluation of existing guidelines on the treatment of atopic dermatitis, publications concerning new biologics and JAK inhibitors not yet incorporated into existing guidelines, and expert-based recommendations. It also includes considerations on atopic dermatitis severity, indications for initiating biologic agents and JAK inhibitors, parameters to be considered in the treatment choice, in particular treatment goals, and recommendations for the use, screening and monitoring of these therapies.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNTorres, TiagoGonçalo, MargaridaLopes, Maria João PaivaClaro, CristinaRamos, LeonorSelores, ManuelaBastos, Pedro MendesRocha, JoanaCarvalho, RodrigoMota, AlbertoFilipe, Paulo2022-02-07T23:23:22Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/132456eng1745-1981PURE: 36508708https://doi.org/10.7573/DIC.2021-9-5info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:11:03Zoai:run.unl.pt:10362/132456Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:47:27.459458Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
title |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
spellingShingle |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients Torres, Tiago Atopic dermatitis Biologic therapy Guidelines JAK inhibitors Recommendations Treatment goals Pharmacology |
title_short |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
title_full |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
title_fullStr |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
title_full_unstemmed |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
title_sort |
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients |
author |
Torres, Tiago |
author_facet |
Torres, Tiago Gonçalo, Margarida Lopes, Maria João Paiva Claro, Cristina Ramos, Leonor Selores, Manuela Bastos, Pedro Mendes Rocha, Joana Carvalho, Rodrigo Mota, Alberto Filipe, Paulo |
author_role |
author |
author2 |
Gonçalo, Margarida Lopes, Maria João Paiva Claro, Cristina Ramos, Leonor Selores, Manuela Bastos, Pedro Mendes Rocha, Joana Carvalho, Rodrigo Mota, Alberto Filipe, Paulo |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Torres, Tiago Gonçalo, Margarida Lopes, Maria João Paiva Claro, Cristina Ramos, Leonor Selores, Manuela Bastos, Pedro Mendes Rocha, Joana Carvalho, Rodrigo Mota, Alberto Filipe, Paulo |
dc.subject.por.fl_str_mv |
Atopic dermatitis Biologic therapy Guidelines JAK inhibitors Recommendations Treatment goals Pharmacology |
topic |
Atopic dermatitis Biologic therapy Guidelines JAK inhibitors Recommendations Treatment goals Pharmacology |
description |
Funding Information: Disclosure and potential conflicts of interest: TT has received research grants and/or consulting fees from AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, LEO Pharma, MSD, Novartis, Pfizer, Samsung-Bioepis, Sandoz and Sanofi. MG has received research grants and/or consulting fees from Abbvie, Leo, Lilly, Novartis, Pfizer, Sanofi and Takeda. MJPL has received research grants and/or consulting fees from AbbVie, Almirall, Janssen, Leo-Pharma, Lilly, Novartis, Pfizer, Sanofi and Viatris. CC has received research grants and/or consulting fees from Janssen, Sanofi-Genzyme, Procter&Gamble, Astellas, Galderma, Leo-Pharma and Mylan. MS has received research grants and/or consulting fees from Janssen, Novartis and Pfizer. PMB has received research grants and/ or consulting fees from AbbVie, Pfizer, Janssen, LEO Pharma, Novartis, Sanofi, Teva, Bayer and L’Oreal. LR, JR, RC, AM and PF have no conflicts of interest to declare. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/11/dic.2021-9-5-COI.pdf Publisher Copyright: Copyright: Copyright © 2021 Torres T, Gonçalo M, Paiva Lopes MJ, Claro C, Ramos L, Selores M, Mendes Bastos P, Rocha J, Carvalho R, Mota A, Filipe P on Behalf of the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021 2021-01-01T00:00:00Z 2022-02-07T23:23:22Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/132456 |
url |
http://hdl.handle.net/10362/132456 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1745-1981 PURE: 36508708 https://doi.org/10.7573/DIC.2021-9-5 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138077424222208 |